A biobank is a biorepository that stores biological samples for research. Biobanks provide data that represent large number of individuals’ samples used by researchers for multiple purposes. Biobanks help in identifying biomarkers of diseases related to single nucleotide polymorphism and others. The global biobanking market was USD 2.26 billion in 2018 and will reach USD 3.81 billion by 2025 at a CAGR of 7.75% during the forecast period.
Growth by Region
North America dominated the market due to increasing research activities, growing interest in biomarker discovery and rising investments in genomics. Asia – Pacific will grow at higher rate in the coming years due to presence of large population base.
Drivers vs Constraints
Factors such as increasing number of genomics research and government & private funding to support regenerative medicine research are driving the market growth. Increased incidence of chronic diseases is further boosting the market. However, lack of high quality samples and ethical & legal issues related to biobanking are restraining the market growth.
Industry Trends and Updates
Bio-Techne acquired Atlanta Biologicals Inc.
Thermo Fisher Scientific acquired the Patheon.
Global Biobanking Market – by Sample Type, Product and Service, Type, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2018 - 2025)
1. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Definition
3.2. Porter's 5 Forces
3.3. Regulations
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends
5. Global Biobanking Market Segmentation, Forecasts and Trends - by Sample Type
5.1. Blood Products
5.2. Human Tissues
5.3. Stem Cells
5.4. Bio-fluids
5.5. Nucleic Acids
5.6. Cell Lines
5.7. Others
6. Global Biobanking Market Segmentation, Forecasts and Trends - by Product and Service
6.1. Equipment
6.2. Consumables
6.3. Services
6.4. Software
6.5. Others
7. Global Biobanking Market Segmentation, Forecasts and Trends - by Type
7.1. Disease Based Biobank
7.2. Population Biobank
7.3. Private Sector Biobank
7.4. Others
8. Global Biobanking Market Segmentation, Forecasts and Trends - by Application
8.1. Regenerative Medicine
8.2. Life Science
8.3. Clinical Research
8.4. Others
9. Global Biobanking Market Segmentation, Forecasts and Trends - by Region
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. UK
9.2.2. France
9.2.3. Germany
9.2.4. Italy
9.2.5. Others
9.3. Asia Pacific
9.3.1. India
9.3.2. China
9.3.3. Japan
9.3.4. Australia
9.3.5. Others
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Others
9.5. Middle East and Africa
9.5.1. South Africa
9.5.2. UAE
9.5.3. Saudi Arabia
9.5.4. Egypt
9.5.5. Others
10. Competitive Intelligence
10.1. Company Market Share Analysis
10.2. Industry M&As, Consolidations
11. Company Profiles
11.1. Thermo Fisher Scientific
11.2. Tecan Group
11.3. Qiagen
11.4. Hamilton
11.5. Brooks Life Sciences
11.6. Promega
11.7. Cureline
11.8. Askion
11.9. PrecisionMed
11.10. Beckman Coulter
11.11. New Brunswick
11.12. BioCision
11.13. VWR Corporation
11.14. Micronic
11.15. Cryo Bio System
11.16. Others
12. Investment Opportunities